Views & Analysis | Perspectives on pharma industry issues

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Articles

Patient-centered research in the Internet age

To begin our R&D innovation focus month, Cal Collins discusses the challenges in clinical research, including clinical trial recruitment, since the rise of social media. In a time when drug development success is becoming scarcer and more expensive, the industry is looking everywhere it...

Articles

Ben Goldacre v Stephen Whitehead: Is pharma getting its act ...

Hannah Blake discusses both sides of the PharmaTimes debate between Ben Goldacre and Stephen Whitehead about achieving clinical trial data transparency. But how did the audience vote? Read on to find out... Is pharma cleaning up its act? Or is it still avoiding the situation? Yesterday saw the first live debate, organised by...

Articles

Influence of medical writers

Darshan Kulkarni highlights the influence that medical writers have when it comes to prescribing and the implications this can have. Medical writers write, edit, or develop materials about medicine and health. They do this by gathering, organizing, interpreting and presenting…

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital